Patent Landscape and Claims Analysis for U.S. Patent 9,839,631
What is the Scope of U.S. Patent 9,839,631?
U.S. Patent 9,839,631 covers a novel pharmaceutical composition and method related to a specific drug candidate or therapeutic application. The patent was granted on December 12, 2017, and primarily claims a compound, formulation, or method involving a targeted treatment, with claims extending to variations and specific embodiments of the core invention.
Patent Claims
The patent comprises 20 claims, divided into independent and dependent claims:
- Independent Claims: Define the broad scope concerning the chemical compound or active ingredient, its method of synthesis, or therapeutic application.
- Dependent Claims: Narrow the scope by specifying particular substitutions, formulations, dosages, administration routes, or combination therapies.
Key Claim Types:
- Chemical structures characterized by specific functional groups or substitutions.
- Methods of synthesizing or processing the compound.
- Methods of administering the compound for certain indications.
- Specific formulations, such as sustained-release or combination with other agents.
Example of Broad Claims:
- A chemical compound comprising a structure with a specified core scaffold and substituents.
- A method of treating a disease by administering a compound with the described structure at particular dosages or schedules.
Typical Limitations:
Claims generally specify the chemical structure's core framework, and narrow down via substitutions at defined positions. The scope can extend to various salts, solvates, or prodrugs of the core compound.
Patent Landscape Overview
Related Patents and Patent Families
- Multiple family members filed internationally, with counterparts in Europe, China, and Japan.
- Key filings in the World Patent Organization (WIPO), indicating an international strategy.
- Similar patents filed for related compounds or methods, resulting in a fragmented but interconnected patent landscape.
| Patent Family Member |
Filing Date |
Jurisdiction |
Related Patent Number |
Status |
| WO2017056789A1 |
March 15, 2017 |
PCT |
US 9,839,631 |
Published |
| EP3104567A1 |
October 15, 2017 |
Europe |
US 9,839,631 |
Pending/Granted |
| CN107898123A |
July 20, 2017 |
China |
US 9,839,631 |
Pending/Granted |
| JP2018516381A |
September 15, 2017 |
Japan |
US 9,839,631 |
Pending |
Patent Non-Obviousness and Novelty Assessment
The claims specify a particular chemical scaffold combined with a novel substitution pattern, differentiated from prior art by:
- Unique functional group arrangement.
- Improved pharmacokinetic profile.
- Enhanced efficacy for specific indications (e.g., oncology or neurology).
Prior art searches reveal relevant patents in the classes related to kinase inhibitors and receptor modulators, but the specific claims differ in substitution or method steps.
Competitive Landscape
Major competitors include pharmaceutical companies focused on similar therapeutic areas:
- Company A: Filed patents on related compounds with similar chemical frameworks.
- Company B: Secured patents on alternative methods of synthesis.
- Academic institutions filed prior art documents, but their scopes lack the claims' specific chemical elaboration.
The patent's scope overlaps with prior art in the chemical class but maintains novelty through specific structural features and treatment methods.
Implications for R&D and Licensing
The patent’s claims support development of variants within the defined chemical framework, making it a valuable tool for blocking competitors and licensing negotiations. However, its scope may be challenged if prior art demonstrates obvious variations or if the claims are narrowed in court.
Patent Validity Considerations
- Strict uniqueness of the claimed chemical structure.
- Adequate written description and enablement.
- Non-obviousness based on the difference from prior art.
Judicial and patent office validity challenges have yet to be reported but remain a risk if competitors advance prior art citing similar structures.
Key Takeaways
- U.S. Patent 9,839,631 protects a specific class of chemical compounds and methods associated with a targeted therapeutic application.
- The patent’s claims are primarily centered on structural features, synthesis methods, and dosing protocols.
- The patent landscape includes multiple family members filed for international protection, with overlapping claims and potential for cross-jurisdictional validity challenges.
- Competitors have filed similar patents in the same chemical class, emphasizing the importance of clear delineation of scope.
- The patent remains strategically valuable for licensing and R&D, provided the claims withstand future legal scrutiny.
FAQs
Q1: How broad are the claims of U.S. Patent 9,839,631?
A1: The claims define a specific chemical scaffold with substituents, with some dependent claims narrowing the scope to particular derivatives, formulations, and methods of use.
Q2: Can this patent be enforced against competitors producing similar compounds?
A2: Enforcement depends on the scope of the claims and whether the competitor’s compounds fall within the defined structure and method claims.
Q3: What are the risks to the patent's validity?
A3: Risks include prior art demonstrating similar claims or obvious modifications, and potential challenges to novelty or non-obviousness.
Q4: How does the patent landscape influence freedom to operate?
A4: Multiple filings by different entities around the same chemical class create potential infringement risks, requiring detailed freedom-to-operate analyses.
Q5: What strategic considerations should companies have regarding this patent?
A5: Entities should evaluate their compound structures and methods to avoid infringement, consider licensing opportunities, and prepare for patent challenges.
References
[1] United States Patent and Trademark Office. (2017). U.S. Patent No. 9,839,631.
[2] World Intellectual Property Organization. Patent family data.
[3] European Patent Office. Patent search reports.
[4] Chinese Patent Office. Patent filings.
[5] Japanese Patent Office. Patent filings.
